Sumitomo Pharma America, Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Sumitomo Pharma America, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Sumitomo Pharma America, Inc.

Sumitomo Pharma America, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ESLICARBAZEPINE ACETATE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: aptiom indicated, treatment partial-onset, seizures patients, years age. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
ESLICARBAZEPINE ACETATE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Sumitomo Pharma America, Inc.

Brand nameGenericTypeRoute
Aptiom ESLICARBAZEPINE ACETATE HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Sumitomo Pharma America, Inc. make?
1 FDA drug label records name Sumitomo Pharma America, Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Sumitomo Pharma America, Inc. produce?
The most frequent active ingredients in this portfolio are ESLICARBAZEPINE ACETATE.

Are Sumitomo Pharma America, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.